Katherine A. Littrell

Investor Relations Kontakt bei Jazz Pharmaceuticals, Inc.

Health Technology

Profil

Katherine A.
Littrell is currently the Vice President-Investor Relations at Jazz Pharmaceuticals, Inc. She previously held the same position at Genentech, Inc. and Jazz Pharmaceuticals Plc.

Aktive Positionen von Katherine A. Littrell

Unternehmen	Position	Beginn
Jazz Pharmaceuticals, Inc. Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.	Investor Relations Kontakt	-

Alle aktiven Positionen von Katherine A. Littrell

Ehemalige bekannte Positionen von Katherine A. Littrell

Unternehmen	Position	Ende
JAZZ PHARMACEUTICALS PLC	Investor Relations Kontakt	-
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Public Communications Contact	-

Sehen Sie sich die Erfahrung von Katherine A. Littrell im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Katherine A. Littrell im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
JAZZ PHARMACEUTICALS PLC	Health Technology

Private Unternehmen	2
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology
Jazz Pharmaceuticals, Inc. Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA.	Health Technology